Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Unilateral U/S PVB 1Stomach Neoplasms 1Pain, Postoperative 1Lung Neoplasms 1Liver Neoplasms 1Liver Diseases 1Head and Neck Neoplasms 1Epstein-Barr Virus Infections 1Diarrhea 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Radiofrequency Ablation 4gadolinium ethoxybenzyl DTPA 2atezolizumab 2Sorafenib 2Oxaliplatin 2Fluorouracil 2Dexmedetomidine 2Bevacizumab 2voxilaprevir 1velpatasvir 1huachansu 1entecavir 1Tobacco Use Cessation Devices 1Tinzaparin 1Telbivudine 1Technetium Tc 99m Aggregated Albumin 1Sofosbuvir 1Sevoflurane 1Ribavirin 1Radionuclide Generators 1Psychiatric Rehabilitation 1Propofol 1Pregabalin 1Polymerase Chain Reaction 1Nivolumab 1Neuroleptanalgesia 1Lamivudine 1Immunotherapy 1Gene Expression Profiling 1Galactose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Liver Neoplasms × Control Groups × Clear all
NCT06173466 2025-06-26

Postoperative Analgesia With Liposomal Bupivacaine Versus Standard Bupivacaine Combined With Dexamethasone

Zhejiang Cancer Hospital

Phase 4 Completed
96 enrolled
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡